Nascent Biotech, Inc. (NBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Oct 14, 2026
Nascent Biotech Market Cap
Nascent Biotech has a market cap or net worth of $34.57 thousand as of October 20, 2026. It is the 51,431st most valuable company in the world and the 7,481st biggest in the United States. Its market cap has decreased by 96.83% in one year.
Market Cap
34.57K
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#7,481 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since August 5, 2014, Nascent Biotech's market cap has decreased from 16.24M to 34.57K, a decrease of -99.79%. That is a compound annual growth rate of -39.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 34.57K | -66.67% |
| Dec 31, 2025 | 103.71K | -98.81% |
| Dec 31, 2024 | 8.74M | -69.97% |
| Dec 29, 2023 | 29.11M | 19.95% |
| Dec 30, 2022 | 24.27M | 341.66% |
| Dec 31, 2021 | 5.49M | 37.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PaxMedica | 63.14K |
| GB Sciences | 52.94K |
| Windtree Therapeutics | 44.99K |
| Itoco | 42.82K |
| Burzynski Research Institute | 26.29K |
| Biostax | 21.65K |
| Carisma Therapeutics | 20.92K |
| Health Sciences Group | 20.51K |